Wei Wan Selected Research

Wei Wan Research Topics

Disease

31	Neoplasms (Cancer) 01/2024 - 11/2009
6	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2017
4	Pulmonary Fibrosis (Fibrosing Alveolitis) 04/2024 - 12/2021
4	Inflammation (Inflammations) 12/2023 - 01/2014
4	Osteosarcoma (Osteogenic Sarcoma) 01/2022 - 01/2019
3	Fibrosis (Cirrhosis) 04/2024 - 12/2021
3	Neuroinflammatory Diseases 01/2024 - 12/2021
3	Cognitive Dysfunction 01/2023 - 11/2020
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 07/2019 - 04/2014
2	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2024 - 01/2024
2	Bites and Stings (Sting) 04/2023 - 01/2023
2	Chromosome Aberrations (Chromosome Abnormalities) 02/2023 - 06/2017
2	Renal Insufficiency (Renal Failure) 02/2023 - 12/2016
2	Anemia 02/2023 - 08/2016
2	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 01/2020
2	Giant Cell Tumors (Giant Cell Tumor) 01/2023 - 02/2019
2	Poisoning 01/2023 - 12/2022
2	Pain (Aches) 09/2022 - 01/2017
2	Infections 06/2022 - 05/2019
2	Pathologic Constriction (Stenosis) 05/2022 - 03/2017
2	Starvation 01/2021 - 02/2015
2	Multiple Myeloma 12/2020 - 06/2017
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2020 - 01/2015
2	Wounds and Injuries (Trauma) 06/2019 - 07/2017
2	Atherosclerosis 05/2019 - 01/2016
1	Hodgkin Disease (Hodgkin's Disease) 04/2024
1	Ocular Hypertension (Glaucoma, Suspect) 03/2024
1	Pericardial Effusion 01/2024
1	Alzheimer Disease (Alzheimer's Disease) 01/2024
1	Weight Loss (Weight Reduction) 01/2024
1	Hypercalcemia (Milk Alkali Syndrome) 02/2023

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2014
7	Nuclear Proteins (Protein, Nuclear)IBA 01/2023 - 01/2016
6	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 04/2023 - 01/2019
5	Ribosomal DNA (rDNA)IBA 12/2022 - 01/2019
5	Biomarkers (Surrogate Marker)IBA 01/2020 - 04/2014
4	Transcription Factors (Transcription Factor)IBA 01/2024 - 12/2022
4	Phosphotransferases (Kinase)IBA 04/2023 - 01/2020
4	Mechanistic Target of Rapamycin Complex 1IBA 01/2021 - 01/2019
3	Sirtuin 1IBA 03/2024 - 02/2015
3	Phosphatidylinositols (Phosphatidylinositol)IBA 04/2023 - 01/2019
3	Phosphates (Orthophosphate)IBA 04/2023 - 01/2019
3	phosphatidylinositol 3-phosphateIBA 04/2023 - 01/2019
3	Autophagy-Related Protein-1 HomologIBA 04/2023 - 01/2019
3	VaccinesIBA 01/2023 - 09/2022
3	TESIBA 01/2023 - 01/2018
3	Sirolimus (Rapamycin)FDA Link 01/2023 - 01/2020
3	Bortezomib (Velcade)FDA Link 12/2020 - 01/2016
2	Retinaldehyde (Retinal)IBA 03/2024 - 01/2012
2	Leucine (L-Leucine)FDA Link 01/2024 - 12/2021
2	Polysaccharides (Glycans)IBA 01/2024 - 11/2015
2	Peptides (Polypeptides)IBA 01/2024 - 01/2024
2	cryptotanshinoneIBA 12/2023 - 03/2022
2	DNA (Deoxyribonucleic Acid)IBA 04/2023 - 01/2023
2	Beclin-1IBA 01/2023 - 01/2019
2	InflammasomesIBA 01/2023 - 11/2020
2	phosphatidylethanolamineIBA 01/2023 - 01/2019
2	UbiquitinIBA 01/2023 - 01/2020
2	CalciumIBA 01/2023 - 04/2012
2	Ribosomal RNAIBA 12/2022 - 12/2020
2	TRPV4 inhibitor HC067047IBA 10/2022 - 12/2021
2	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 01/2020
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2021
2	Green Fluorescent ProteinsIBA 12/2020 - 01/2019
2	AlbuminsIBA 01/2020 - 12/2016
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 06/2019 - 01/2019
2	fibrin fragment D (D-dimer)IBA 02/2019 - 01/2019
1	Fibronectins (Fibronectin)IBA 04/2024
1	cysteinyl-arginyl-glutamyl-lysyl-alanylIBA 04/2024
1	Liposomes (Liposome)IBA 04/2024
1	Therapeutic UsesIBA 04/2024
1	ResveratrolIBA 03/2024
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2024
1	Lipocalin-2IBA 01/2024
1	AntigensIBA 01/2024
1	AntibodiesIBA 01/2024
1	squamous cell carcinoma-related antigenIBA 01/2024
1	Amyloid (Amyloid Fibrils)IBA 01/2024
1	big gastrinIBA 01/2024
1	Apolipoprotein E4IBA 01/2024
1	Transient Receptor Potential ChannelsIBA 01/2024
1	B7-H1 AntigenIBA 01/2024
1	hemoglobin P (Hb P)IBA 01/2024
1	Tumor Biomarkers (Tumor Markers)IBA 01/2024
1	Keratins (Keratin)IBA 01/2024
1	XylansIBA 01/2024
1	Carcinoembryonic AntigenIBA 01/2024
1	Uric Acid (Urate)IBA 01/2024
1	CarbonatesIBA 01/2024
1	pro-gastrin-releasing peptide (31-98)IBA 01/2024
1	Matrix Metalloproteinases (MMPs)IBA 12/2023
1	InterferonsIBA 04/2023
1	Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA 04/2023
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 04/2023
1	Alkaline PhosphataseIBA 03/2023

Therapy/Procedure

16	Therapeutics 04/2024 - 01/2016
5	Drug Therapy (Chemotherapy) 03/2023 - 04/2014
5	Radiotherapy 01/2023 - 08/2014
2	Self Expandable Metallic Stents 05/2022 - 03/2017
2	Hematopoietic Stem Cell Transplantation 07/2019 - 12/2013